Holen Sie sich die Stockscreener-App
13.70
0.29%
-0.04
Vorhandelsmarkt:
13.66
-0.04
-0.29%
Janux Therapeutics Inc Aktie (JANX) Neueste Nachrichten
Behavioral Patterns of JANX and Institutional Flows - Stock Traders Daily
JANX SEC FilingsJanux Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Top Cybin (HELP) Competitors 2026 - MarketBeat
Janux Therapeutics (JANX) details RSU and stock option grants to RA Capital–linked entities - Stock Titan
Janux Therapeutics (JANX) director reports RSU and option awards tied to RA Capital - Stock Titan
Janux Therapeutics (JANX) awards director RSUs and 15,500 options - Stock Titan
Janux Therapeutics (JANX) director awarded RSUs and stock options - Stock Titan
Director at Janux Therapeutics (JANX) gets new RSUs and stock options - Stock Titan
Janux Therapeutics Reports Results of 2026 Annual Meeting - TipRanks
Shareholders back Janux Therapeutics (NASDAQ: JANX) board and pay - Stock Titan
Janux Therapeutics, Inc. (JANX) reports Q1 loss, lags revenue estimates - MSN
How much upside is left in Janux Therapeutics (JANX)? Wall Street analysts think 180.44% - MSN
Janux Therapeutics (JANX) Q1 2026 Earnings: Better-than-Expected Loss Reduction Highlights Pipeline ProgressNew Analyst Coverage - newsline.com
JANX News | JANUX THERAPEUTICS INC (NASDAQ:JANX) - ChartMill
B of A Securities Maintains Janux Therapeutics (JANX) Buy Recommendation - MSN
JANX Technical Analysis & Stock Price Forecast - Intellectia AI
Janux Therapeutics officer Janeen Doyle sells $56,943 in stock By Investing.com - Investing.com Australia
(JANX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Janux Therapeutics officer Janeen Doyle sells $56,943 in stock - Investing.com UK
Janux Therapeutics (JANX) officer auto-sells 4,059 shares to cover RSU taxes - Stock Titan
4,059 RSUs to be Sold by JANX (NASDAQ: JANX) - Stock Titan
JANX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Janux Therapeutics Q1 2026 Earnings: Narrower Loss Surprises, Stock Edges LowerEarnings Power Value - thelegaladvocate.com
Janux Therapeutics, Inc.Common Stock (NQ: JANX - FinancialContent
Wall Street analysts predict a 155.82% upside in Janux Therapeutics (JANX): Here's what you should know - MSN
Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know - Yahoo Finance
JANX: Janux TherapeuticsPrice & Consenus Chart - Zacks Investment Research
Here's Why You Should Add JANX Stock to Your Portfolio Now - TradingView
JANX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
How (JANX) Movements Inform Risk Allocation Models - Stock Traders Daily
Analyst Reiterates Buy on Janux Therapeutics, Citing Deep Pipeline Catalysts and Compelling Risk/Reward at Near-Zero Enterprise Value - TipRanks
JANX Q1 2026 Earnings: Narrowed Loss Beats Estimates; Clinical Pipeline Progress UnderwayManagement Tone Analysis - newsline.com
Janux secures $35 million milestone payment from Bristol Myers Squibb - MSN
Janux Therapeutics (JANX) price target decreased by 14.60% to 42.12 - MSN
Janus Henderson (JANX) discloses 4.2M shares, 6.9% passive stake - Stock Titan
Trading Systems Reacting to (JANX) Volatility - Stock Traders Daily
Insider Sell: Maria Dobek Sells Shares of Janux Therapeutics Inc (JANX) - GuruFocus
Janux Therapeutics VP Maria Dobek sells $28,878 in stock By Investing.com - Investing.com Australia
Janux Therapeutics VP Maria Dobek sells $28,878 in stock - Investing.com
Janux Therapeutics (JANX) VP sells 2,038 shares at $14.17 - Stock Titan
Bullish: Analysts Just Made A Meaningful Upgrade To Their Janux Therapeutics, Inc. (NASDAQ:JANX) Forecasts - simplywall.st
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):